Altimmune Inc (ALT)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Vipin K. Garg
Employees:
50
19 FIRSTFIELD ROAD, GAITHERSBURG, MD 20878
2406541450

Altimmune, Inc. focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis.

Data derived from most recent annual or quarterly report
Market Cap 745.251 Million Shares Outstanding49.159 Million Avg 30-day Volume 1.402 Million
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue189.6118 Debt to Equity0.022 EBITDA-88.307 Million
Price to Book Value3.0698 Operating Margin-2670.1276 Enterprise Value432.034 Million
Current Ratio13.404 EPS Growth0 Quick Ratio12.861
1 Yr BETA 1.1664 52-week High/Low 23.49 / 3.83 Profit Margin-2619.2678
Operating Cash Flow Growth3.3163 Altman Z-Score16.1957 Free Cash Flow to Firm -58.805 Million
Earnings Report2023-03-15

Are you looking for this stock instead?

View SEC Filings from ALT instead.

View recent insider trading info

Funds Holding ALT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALT

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-12-20:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-29:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-09-14:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-17:
    Item 1.02: Termination of a Material Definitive Agreement
  • 8-K: filed on 2021-12-13:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    20 Thousand total shares from 1 transactions

    Exercise Derivative Conversion (M)

    61.4 Thousand total shares from 5 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    EISENSTADT RICHARD I CHIEF FINANCIAL OFFICER

    • Officer
    12,010 2023-01-31 4

    GARG VIPIN K PRESIDENT AND CEO

    • Officer
    • Director
    238,601 2023-01-31 13

    ROBERTS M SCOT CHIEF SCIENTIFIC OFFICER

    • Officer
    24,944 2023-01-31 6

    HARRIS MATTHEW SCOTT CHIEF MEDICAL OFFICER

    • Officer
    17,900 2023-01-31 4

    JORDT RAYMOND M CHIEF BUSINESS OFFICER

    • Officer
    0 2023-01-03 2

    PISANO WAYNE

    • Director
    8,498 2022-12-22 2

    DRUTZ DAVID

    • Director
    20,484 2022-11-18 4

    SAYARE MITCHEL

    • Director
    23,500 2022-09-29 1

    GILL JOHN

    • Director
    23,500 2022-09-29 1

    JORKASKY DIANE

    • Director
    23,500 2022-09-29 2

    HODGES PHILIP

    • Director
    23,500 2022-09-29 1

    SCHAFER KLAUS

    • Director
    23,500 2022-09-29 2

    BROWN WILLIAM MICHAEL CHIEF FINANCIAL OFFICER

    • Officer
    17,721 2021-07-31 0

    VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.

    VHCP CO-INVESTMENT HOLDINGS III, LLC

    VHCP MANAGEMENT III, LLC

    VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.

    VHCP CO-INVESTMENT HOLDINGS II, LLC

    VHCP MANAGEMENT II, LLC

    KOH BONG Y

    SHAH NIMISH P

    • 10% Owner
    No longer subject to file 2021-02-25 0

    VELOCITY PHARMACEUTICAL HOLDINGS LLC

    • 10% Owner
    No longer subject to file 2020-05-14 0

    VELOCITY PHARMACEUTICAL HOLDINGS LLC

    COLLIER DAVID J

    WATSON JAMES F

    VELOCITY PHARMA MANAGEMENT, LLC

    • 10% Owner
    1,887,250 2019-07-12 0

    TASKER SYBIL CHIEF MEDICAL OFFICER

    • Officer
    0 2019-06-17 0

    NOVARTIS BIOVENTURES LTD

    NOVARTIS AG

    • 10% Owner
    No longer subject to file 2018-10-02 0

    ENRIGHT WILLIAM PRESIDENT AND CEO

    • Officer
    • Director
    365,839 2018-05-25 0

    TRUFFLE CAPITAL S.A.S.

    • 10% Owner
    2,161,802 2018-02-13 0

    SCHAFFER DERACE L

    • Director
    1,152,600 2017-12-28 0

    HODGES PHILIP

    REDMONT VAXN CAPITAL HOLDINGS, LLC

    • Director
    0 2017-10-13 1

    CZEREPAK ELIZABETH CFO AND EVP CORP. DEVELOPMENT

    • Officer
    0 2017-09-22 0

    HODGES PHILIP

    REDMONT VAXN CAPITAL HOLDINGS, LLC

    PARADIGM VENTURE PARTNERS, L.P.

    REDMONT VENTURE PARTNERS, INC.

    • Director
    • 10% Owner
    0 2017-05-04 0

    RUNGE JEFFREY W.

    • Director
    197,700 2017-01-20 0

    ST PETER STEVEN

    • Director
    205,004 2017-01-04 0

    MACNEILL PHILIP VP, CFO, TREASURER, SECRETARY

    • Officer
    126,346 2016-12-21 0

    PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.

    FROHLICH PHIL

    • 10% Owner
    No longer subject to file 2016-12-07 0

    RICHMAN ERIC I

    • Director
    908,055 2016-11-22 0

    JONES JEFFREY MICHAEL COO

    • Officer
    27,544 2015-03-11 0

    CHANG LINDA L SVP, CFO & SECRETARY

    • Officer
    30,000 2015-01-07 0

    MARKISON BRIAN A

    • Director
    0 2014-12-31 0

    MCCLEARY JOEL

    • Director
    0 2014-12-31 0

    COOK FRANCESCA M SVP, POLICY & GOV'T AFFAIRS

    • Officer
    0 2014-12-08 0

    MORGES WAYNE SVP, REG. AFFAIRS & QUALITY

    • Officer
    0 2014-12-08 0

    KARP JORDAN P SVP, GENERAL COUNSEL

    • Officer
    0 2012-12-03 0

    FUERST THOMAS RICHARD EVP, CHIEF SCIENTIFIC OFFICER

    • Officer
    0 2011-12-01 0

    PAPPAJOHN JOHN

    • Director
    0 2011-06-23 0

    RIDDLE VALERIE D SVP, MEDICAL DIRECTOR

    • Officer
    44,436 2011-05-25 0

    REINHART CHARLES A. III SVP, CHIEF FINANCIAL OFFICER

    • Officer
    0 2010-12-08 0

    HEALTHCARE VENTURES VII LP

    LAWLOR AUGUSTINE

    LITTLECHILD JOHN W

    MIRABELLI CHRISTOPHER

    WERNER HAROLD R

    CAVANAUGH JAMES H

    HEALTHCARE PARTNERS VII, L.P.

    • Director
    • 10% Owner
    4,253,057 2010-11-03 0

    EVNIN LUKE

    GALAKATOS NICHOLAS

    HENNER DENNIS

    STEINMETZ MICHAEL

    GADICKE ANSBERT

    WHEELER KURT

    SIMON NICHOLAS J III

    • 10% Owner
    6,347,614 2010-11-03 0

    MPM BIOVENTURES III LLC

    MPM BIOVENTURES III PARALLEL FUND, L.P.

    MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG

    MPM BIOVENTURES III L.P.

    MPM BIOVENTURES III GP L.P.

    MPM BIOVENTURES III-QP L.P.

    MPM ASSET MANAGEMENT INVESTORS 2004 BVIII LLC

    • 10% Owner
    6,347,614 2010-11-03 0

    CAVANAUGH JAMES H

    • Director
    • 10% Owner
    0 2010-06-23 0

    FUSCO JOAN SVP, OPERATIONS

    • Officer
    0 2010-05-06 0

    CAMUT CHRISTOPHER C VP, GOV'T CONTRACTS

    • Officer
    No longer subject to file 2010-01-21 0

    WRIGHT DAVID P PRESIDENT AND CEO

    • Officer
    • Director
    399,500 2009-12-11 0

    PRICE KEVIN PRESIDENT - PHARMATHENE UK,LTD

    • Officer
    0 2009-01-21 0

    HEALTHCARE VENTURES VII LP

    HEALTHCARE PARTNERS VII, L.P.

    CAVANAUGH JAMES H

    LITTLECHILD JOHN W

    WERNER HAROLD R

    LAWLOR AUGUSTINE

    MIRABELLI CHRISTOPHER

    AGUIAR ERIC

    • Director
    • 10% Owner
    5,109,690 2007-08-03 0

    MILLENCO, L.L.C.

    MILLENNIUM MANAGEMENT, L.L.C.

    ENGLANDER ISRAEL A

    • 10% Owner
    1,200,000 2007-08-03 0

    GADICKE ANSBERT

    • 10% Owner
    996 2007-08-03 0

    BERGER EDWARD B

    • FORMER DIRECTOR
    22,500 2007-08-03 0

    SCHELLHAMMER WAYNE A

    • FORMER DIRECTOR
    22,500 2007-08-03 0

    KINLEY MATTHEW P

    • FORMER PRESIDENT & TREASURER
    611,980 2007-08-03 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    ROBERTS M SCOT - Officer CHIEF SCIENTIFIC OFFICER

    2023-02-02 17:11:14 -0500 2023-02-01 M 6,166 d 12,332 direct

    ROBERTS M SCOT - Officer CHIEF SCIENTIFIC OFFICER

    2023-02-02 17:11:14 -0500 2023-02-01 F 2,183 $13.78 d 14,456 direct

    ROBERTS M SCOT - Officer CHIEF SCIENTIFIC OFFICER

    2023-02-02 17:11:14 -0500 2023-02-01 M 6,166 a 16,639 direct

    HARRIS MATTHEW SCOTT - Officer CHIEF MEDICAL OFFICER

    2023-02-02 17:10:41 -0500 2023-02-01 M 6,166 d 12,332 direct

    HARRIS MATTHEW SCOTT - Officer CHIEF MEDICAL OFFICER

    2023-02-02 17:10:41 -0500 2023-02-01 F 2,183 $13.78 d 17,900 direct

    HARRIS MATTHEW SCOTT - Officer CHIEF MEDICAL OFFICER

    2023-02-02 17:10:41 -0500 2023-02-01 M 6,166 a 20,083 direct

    GARG VIPIN K - Director - Officer PRESIDENT AND CEO

    2023-02-02 17:09:43 -0500 2023-02-01 M 16,546 d 33,090 direct

    GARG VIPIN K - Director - Officer PRESIDENT AND CEO

    2023-02-02 17:09:43 -0500 2023-02-01 F 7,658 $13.78 d 238,601 direct

    GARG VIPIN K - Director - Officer PRESIDENT AND CEO

    2023-02-02 17:09:43 -0500 2023-02-01 M 16,546 a 246,259 direct

    ROBERTS M SCOT - Officer CHIEF SCIENTIFIC OFFICER

    2023-02-02 17:11:14 -0500 2023-01-31 A 1,436 $10.21 a 10,473 direct

    HARRIS MATTHEW SCOTT - Officer CHIEF MEDICAL OFFICER

    2023-02-02 17:10:41 -0500 2023-01-31 A 1,296 $10.21 a 13,917 direct

    GARG VIPIN K - Director - Officer PRESIDENT AND CEO

    2023-02-02 17:09:43 -0500 2023-01-31 A 1,938 $10.21 a 229,713 direct

    EISENSTADT RICHARD I - Officer CHIEF FINANCIAL OFFICER

    2023-02-02 17:09:00 -0500 2023-01-31 A 1,172 $10.21 a 12,010 direct

    GARG VIPIN K - Director - Officer PRESIDENT AND CEO

    2023-02-01 17:33:13 -0500 2023-01-30 A 302,900 a 302,900 direct

    GARG VIPIN K - Director - Officer PRESIDENT AND CEO

    2023-02-01 17:33:13 -0500 2023-01-30 A 107,100 a 107,100 direct

    ROBERTS M SCOT - Officer CHIEF SCIENTIFIC OFFICER

    2023-02-01 17:31:51 -0500 2023-01-30 A 37,100 a 37,100 direct

    ROBERTS M SCOT - Officer CHIEF SCIENTIFIC OFFICER

    2023-02-01 17:31:51 -0500 2023-01-30 A 105,000 a 105,000 direct

    EISENSTADT RICHARD I - Officer CHIEF FINANCIAL OFFICER

    2023-02-01 17:31:05 -0500 2023-01-30 A 37,100 a 37,100 direct

    EISENSTADT RICHARD I - Officer CHIEF FINANCIAL OFFICER

    2023-02-01 17:31:05 -0500 2023-01-30 A 105,000 a 105,000 direct

    HARRIS MATTHEW SCOTT - Officer CHIEF MEDICAL OFFICER

    2023-02-01 17:30:31 -0500 2023-01-30 A 37,100 a 37,100 direct

    HARRIS MATTHEW SCOTT - Officer CHIEF MEDICAL OFFICER

    2023-02-01 17:30:31 -0500 2023-01-30 A 105,000 a 105,000 direct

    JORDT RAYMOND M - Officer CHIEF BUSINESS OFFICER

    2023-01-04 16:06:00 -0500 2023-01-03 A 37,500 a 37,500 direct

    JORDT RAYMOND M - Officer CHIEF BUSINESS OFFICER

    2023-01-04 16:06:00 -0500 2023-01-03 A 125,000 a 125,000 direct

    EISENSTADT RICHARD I - Officer CHIEF FINANCIAL OFFICER

    2023-01-03 17:59:54 -0500 2022-12-31 M 12,500 d 37,500 direct

    EISENSTADT RICHARD I - Officer CHIEF FINANCIAL OFFICER

    2023-01-03 17:59:54 -0500 2022-12-31 F 3,028 $16.45 d 10,838 direct -3.1735 5.1317 5.1317 6 -5.6718 4

    EISENSTADT RICHARD I - Officer CHIEF FINANCIAL OFFICER

    2023-01-03 17:59:54 -0500 2022-12-31 M 12,500 a 13,866 direct -3.1735 5.1317 5.1317 6 -5.6718 4

    PISANO WAYNE - Director

    2022-12-22 16:05:36 -0500 2022-12-22 M 20,000 $2.60 a 28,498 direct -3.3268 1.9569 7.3059 5 -3.8487 3

    PISANO WAYNE - Director

    2022-12-22 16:05:36 -0500 2022-12-22 M 20,000 d 0 direct

    PISANO WAYNE - Director

    2022-12-22 16:05:36 -0500 2022-12-22 S 20,000 $15.01 d 8,498 direct yes -3.3268 1.9569 7.3059 5 -3.8487 3

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ALTIMMUNE INC ALT 2023-02-03 22:15:03 UTC 4.0397 0.5303 2000000
    ALTIMMUNE INC ALT 2023-02-03 21:45:03 UTC 4.0397 0.5303 2000000
    ALTIMMUNE INC ALT 2023-02-03 21:15:03 UTC 4.0397 0.5303 2000000
    ALTIMMUNE INC ALT 2023-02-03 20:45:06 UTC 4.0397 0.5303 2000000
    ALTIMMUNE INC ALT 2023-02-03 20:15:04 UTC 4.0397 0.5303 2000000
    ALTIMMUNE INC ALT 2023-02-03 19:45:03 UTC 4.0397 0.5303 2000000
    ALTIMMUNE INC ALT 2023-02-03 19:15:04 UTC 4.0397 0.5303 2000000
    ALTIMMUNE INC ALT 2023-02-03 18:45:03 UTC 4.0397 0.5303 2000000
    ALTIMMUNE INC ALT 2023-02-03 18:15:03 UTC 4.0397 0.5303 2000000
    ALTIMMUNE INC ALT 2023-02-03 17:45:03 UTC 4.0397 0.5303 2000000
    ALTIMMUNE INC ALT 2023-02-03 17:15:04 UTC 4.0397 0.5303 2000000
    ALTIMMUNE INC ALT 2023-02-03 16:45:04 UTC 4.042 0.528 2000000
    ALTIMMUNE INC ALT 2023-02-03 16:15:03 UTC 4.042 0.528 2000000
    ALTIMMUNE INC ALT 2023-02-03 15:45:03 UTC 4.042 0.528 2000000
    ALTIMMUNE INC ALT 2023-02-03 15:15:03 UTC 4.042 0.528 2000000
    ALTIMMUNE INC ALT 2023-02-03 14:45:04 UTC 3.8375 0.4825 2000000
    ALTIMMUNE INC ALT 2023-02-03 14:15:04 UTC 3.8375 0.4825 2000000
    ALTIMMUNE INC ALT 2023-02-03 13:45:03 UTC 3.8375 0.4825 2000000
    ALTIMMUNE INC ALT 2023-02-03 13:15:03 UTC 3.8375 0.4825 1900000
    ALTIMMUNE INC ALT 2023-02-03 12:45:03 UTC 3.8375 0.4825 1900000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments